Glucagon-Like Peptide-2 as a Potential Biomarker for Nonalcoholic Fatty Liver Disease in Children with Obesity: Preliminary Assessment of Metabolic Associations and Underlying Mechanisms

Zhang SJ, Xu K, Zhu F, Teng YQ, Tang YF, Xu HW

Diabetes, Metabolic Syndrome and Obesity 2025, 18:3515-3525

Published Date: 18 September 2025